Safety, PK, and preliminary antitumor activity of the oral EGFR/HER2 exon 20 inhibitor TAK-788 in NSCLC Meeting Abstract
| Authors: | Neal, J.; Doebele, R.; Riely, G.; Spira, A.; Horn, L.; Piotrowska, Z.; Costa, D.; Zhang, S.; Bottino, D.; Zhu, J.; Kerstein, D.; Li, S.; Jänne, P. |
| Abstract Title: | Safety, PK, and preliminary antitumor activity of the oral EGFR/HER2 exon 20 inhibitor TAK-788 in NSCLC |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | her2 mutation; egfr exon 20 mutation; egfr tyrosine kinase inhibitor |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S599 |
| Language: | English |
| ACCESSION: | WOS:000454014502056 |
| DOI: | 10.1016/j.jtho.2018.08.901 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1.13-44 -- Source: Wos |
